FDA Inspection
OneBlood, Inc.OneBlood, Inc. – FDA Inspection, Sep 7, 2010
Record Details
This FDA Inspection record concerns OneBlood, Inc., with an inspection on September 7, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- OneBlood, Inc.
- Inspection Date
- September 7, 2010
- Product Type
- Biologics
View Company Profile
ID · e49b95e2-1935-4533-9704-e615dc41ab77
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 680694
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 606.170(a)Adverse Reaction - Investigations
- 21 CFR 606.171Biological product deviation report
- 21 CFR 606.160(a)(1)Person performing, test results, interpretation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of OneBlood, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for OneBlood, Inc.
- FDA Inspection 789927 - 2012-06-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.